Results 231 to 240 of about 228,725 (267)
Some of the next articles are maybe not open access.
World Journal of Surgery, 1985
AbstractWith increasing experience in the surgical management of children with congenital heart disease has come an increasing use of prosthetic valves. They have been employed in a wide variety of conditions ranging from simple congenital stenosis or incompetence to an essential part of repair of more complex disorders.
Martin Elliott, M. De Leval
openaire +3 more sources
AbstractWith increasing experience in the surgical management of children with congenital heart disease has come an increasing use of prosthetic valves. They have been employed in a wide variety of conditions ranging from simple congenital stenosis or incompetence to an essential part of repair of more complex disorders.
Martin Elliott, M. De Leval
openaire +3 more sources
The Annals of Thoracic Surgery, 1968
he development of the ball-valve prosthesis for replacement of the diseased aortic valve by Starr et al. [22] extended operability T to many patients for whom palliative surgical treatment had not been previously available. Many of these patients now survive and are subject to the benefits and risks of this prosthesis, for which the long-term results ...
Kent W. Jones+2 more
openaire +3 more sources
he development of the ball-valve prosthesis for replacement of the diseased aortic valve by Starr et al. [22] extended operability T to many patients for whom palliative surgical treatment had not been previously available. Many of these patients now survive and are subject to the benefits and risks of this prosthesis, for which the long-term results ...
Kent W. Jones+2 more
openaire +3 more sources
The Thoracic and Cardiovascular Surgeon, 1987
The performance of the St. Jude prosthetic valve is reviewed in 81 patients aged 3 to 15 years. All 66 mitral (2 re-replacements), 8 aortic and 9 double valve replacements between February 1979 and August 1984 are included. The early mortality was 3.7% and actuarial analysis shows a 90% event free survival up to 5 years.
Derek G. Human+6 more
openaire +3 more sources
The performance of the St. Jude prosthetic valve is reviewed in 81 patients aged 3 to 15 years. All 66 mitral (2 re-replacements), 8 aortic and 9 double valve replacements between February 1979 and August 1984 are included. The early mortality was 3.7% and actuarial analysis shows a 90% event free survival up to 5 years.
Derek G. Human+6 more
openaire +3 more sources
Mitral Valve Replacement in Patients After Aortic Valve Replacement
Journal of Cardiac Surgery, 1985Abstract Background: Mitral valve replacement in patients who previously had undergone aortic valve replacement is a technical challenge. The rigid aortic prosthesis limits visualization of the anterior mitral annulus and placement of sutures. Methods: Reoperative mitral valve replacement was performed in five patients after aortic valve replacement ...
Gideon Merin, Ehud Rudis, Amir Elami
openaire +4 more sources
Semilunar Valve Replacement with a Cylindrical Valve
Journal of Cardiac Surgery, 1993A cylindrical valve was designed to prevent regurgitation of the semilunar valve. The valve is made of a sheet of polytetrafluoroethylene (PTFE) or porcine pericardium, and has three cusps and three commissures. The diameter of the valve is equal to the height of the cusps.
Matsumoto T+5 more
openaire +3 more sources
AORN Journal, 1982
Patricia C Seifert, RN, BA, CNOR, is head nurse in cardiac surgery at the Fairfax Hospital, Falls Church, Va. An AD graduate of Northern Virginia Community College School of Nursing, Annandale, Va, she received her bachelor’s degree from Trinity College, Washington, DC.
openaire +3 more sources
Patricia C Seifert, RN, BA, CNOR, is head nurse in cardiac surgery at the Fairfax Hospital, Falls Church, Va. An AD graduate of Northern Virginia Community College School of Nursing, Annandale, Va, she received her bachelor’s degree from Trinity College, Washington, DC.
openaire +3 more sources
Tricuspid valve replacement with a bioprosthetic valve
Multimedia Manual of Cardio-Thoracic Surgery, 2008Significant tricuspid regurgitation (TR) is present in many patients with heart failure. Valve replacement is necessary in patients in whom the valve is irreparable or in whom there is a high risk of late failure. The following manuscript and videos describe our approach to tricuspid valve replacement with a bioprosthetic valve.
Richard T. Lee+4 more
openaire +3 more sources